Home/Cambium Oncology/Gary Altman, PhD

GA

Gary Altman, PhD

CEO and Director

Cambium Oncology

Therapeutic Areas

Cambium Oncology Pipeline

Drug	Indication	Phase
CAMV-01 (Small Molecule)	Cancer (VIP/VPAC high)	Pre-clinical
ANT308	Cancer	Pre-clinical
CART-ANT308	Pancreatic Cancer / Solid Tumors	Pre-clinical
Fc-ANT308	Cancer	Pre-clinical

Leadership Team at Cambium Oncology

Ned Waller, MD, PhD, FACP

Founder & Chairman of the Board

Giovanni Selvaggi, MD

Chief Medical Officer and Director

Terence Walts, MBA

Chief Business Advisor and Director

View full Cambium Oncology profile